Fundamentals

Cytomed Therapeutics Ltd

GDTC

Soon

Sentiment

Soon

Options

Revenue

69.50k

▲69.50k∞%

-

Assets

10.07M

▼-2.30M▼-18.60%

12 Months Change

Liabilities

1.02M

▼-100.76k▼-8.96%

12 Months Change

Free Cash Flow

-4.11M

▼-520.66k▼-14.51%

12 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001493152-24-015594

ID: 0001493152-23-015042